share_log

HC Wainwright & Co. Initiates Coverage On GRI Bio With Buy Rating, Announces Price Target of $10

HC Wainwright & Co. Initiates Coverage On GRI Bio With Buy Rating, Announces Price Target of $10

HC Wainwright & Co. 开始对GRI Bio进行覆盖,给予买入评级,宣布目标价格为10美元。
Benzinga ·  12/09 19:20  · 评级/大行评级

HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on GRI Bio (NASDAQ:GRI) with a Buy rating and announces Price Target of $10.

HC Wainwright & Co. 分析师约瑟夫·潘吉尼斯开始对GRI Bio(纳斯达克股票代码:GRI)进行报道,评级为买入,并宣布目标股价为10美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发